Factors Underlying the Characteristic Inhibition of the Neuronal Release of Transmitters by Tetanus and Various Botulinum Toxins
10.1007/978-1-4757-9542-4_20
Crossref book-chapter
Springer US
Botulinum and Tetanus Neurotoxins (297)
Bibliography

Ashton, A. C., de Paiva, A. M., Poulain, B., Tauc, L., & Dolly, J. O. (1993). Factors Underlying the Characteristic Inhibition of the Neuronal Release of Transmitters by Tetanus and Various Botulinum Toxins. Botulinum and Tetanus Neurotoxins, 191–213.

Authors 5
  1. Anthony C. Ashton (first)
  2. Anton M. de Paiva (additional)
  3. Bernard Poulain (additional)
  4. Ladislav Tauc (additional)
  5. J. Oliver Dolly (additional)
References 77 Referenced 0
  1. U. Eisel, W. Jarausch, K. Goretzki, A. Henschen, J. Engels, U. Weller, M. Hudel, E. Habermann, and H. Niemann, Tetanus toxin: primary structure, expression in E.coli, and homology with botulinum toxins, EMBO J. 5: 2495–2502 (1986). (10.1002/j.1460-2075.1986.tb04527.x) / EMBO J by U Eisel (1986)
  2. H. Niemann, Molecular biology of Clostridial toxins, in: “Sourcebook of Bacterial Protein Toxins,” J. Alouf and J. Freer ed., Academic Press, London (1991). / “Sourcebook of Bacterial Protein Toxins,” J by H Niemann (1991)
  3. D. E. Thompson, J. K. Brehm, J. D. Oultram, T.-L. Swinfield, C. C. Shone, T. Atkinson, J. Melling, and N. P. Minton, The complete amino acid sequence of the Clostridium botulinum type A neurotoxin deduced by nucleotide sequence analysis of the encoding gene, Eur.J.Biochem. 189: 73–81 (1990). (10.1111/j.1432-1033.1990.tb15461.x) / Eur.J.Biochem. by DE Thompson (1990)
  4. L. L. Simpson (ed.). “Botulinum Neurotoxin and Tetanus Toxin”, Academic Press, New York (1989). / “Botulinum Neurotoxin and Tetanus Toxin” (1989)
  5. J. O. Dolly, Peptide toxins that alter neurotransmitter release, in: “Handbook of Experimental Pharmacology, Vol. 102. Selective Neurotoxicity,” H. Herken and F. Hucho eds., Springer-Verlag, Berlin (1992). / “Handbook of Experimental Pharmacology, Vol. 102. Selective Neurotoxicity,” H. Herken and F. Hucho eds. by JO Dolly (1992)
  6. F. Dreyer and A. Schmitt, Different effects of botulinum A toxin and tetanus toxin on the transmitter releasing process at the mammalian neuromuscular junction, Neuroscience Lett. 26: 307–311 (1981). (10.1016/0304-3940(81)90150-6) / Neuroscience Lett by F Dreyer (1981)
  7. F. Dreyer and A. Schmitt, Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates and its dependence on nerve stimulation and temperature, Pflügers Archiv Eur.J.Physiol. 399: 228–234 (1983). (10.1007/BF00656720) / Pflügers Archiv Eur.J.Physiol. by F Dreyer (1983)
  8. M. Gansel, R. Penner, and F. Dreyer, Distinct sites of action of Clostridial neurotoxins revealed by double-poisoning of mouse motor nerve terminals, Pflugers Arch. 409: 533–539 (1987). (10.1007/BF00583812) / Pflugers Arch by M Gansel (1987)
  9. J. Molgó, L. S. Siegel, N. Tabti, and S. Thesleff, A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D, J.Physiol. 411: 195–205 (1989). (10.1113/jphysiol.1989.sp017568) / J.Physiol. by J Molgó (1989)
  10. L. Wieszt and F. Dreyer, Mode of action of botulinum type E on the transmitter release process at the mouse neuromuscular junction, Naunyn-Schmeideberg’s Arch Pharmacol. 344 (suppl.): R74 (1991). / E on the transmitter release process at the mouse neuromuscular junction, Naunyn-Schmeidebergs Arch Pharmacol by L Wieszt (1991)
  11. J. Molgó, B. R. DasGupta, and S. Thesleff, Characterization of the actions of botulinum neurotoxin type E at the rat neuromuscular junction, Acta Physiol Scand. 137: 497–501 (1989). (10.1111/j.1748-1716.1989.tb08786.x) / E at the rat neuromuscular junction, Acta Physiol Scand by J Molgó (1989)
  12. L. C. Sellin, S. Thesleff, and B. R. DasGupta, Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction, Acta Physiol.Scand. 119: 127–133 (1983). (10.1111/j.1748-1716.1983.tb07317.x) / Acta Physiol.Scand. by LC Sellin (1983)
  13. L. S. Siegel, A. D. Johnson-Winegar, and L. C. Sellin, Effect of 3,4diaminopyridine on the survival of mice injected with botulinum neurotoxin type A, B, E, or F, Toxicol.appl. Pharmac. 84: 255 (1986). (10.1016/0041-008X(86)90133-X) / Toxicol.appl. Pharmac. by LS Siegel (1986)
  14. L. L. Simpson, Use of pharmacologic antagonists to deduce commonalities of biologic activity among Clostridial neurotoxins, J.Pharmacol.Exp.Ther. 245: 867–872 (1988). (10.1016/S0022-3565(25)24065-4) / J.Pharmacol.Exp.Ther. by LL Simpson (1988)
  15. I. Kao, D. B. Drachman, and D. L. Price, Botulinum toxin: mechanism of presynaptic blockade, Science. 193: 1256–1258 (1976). (10.1126/science.785600) / Science by I Kao (1976)
  16. S. G. Cull-Candy, H. Lundh, and S. Thesleff, Effects of botulinum toxin on neuromuscular transmission in the rat, J.Physiol. 260: 177–203 (1976). (10.1113/jphysiol.1976.sp011510) / J.Physiol. by SG Cull-Candy (1976)
  17. F. Dreyer, F. Rosenberg, C. Becker, H. Bigalke, and R. Penner, Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin, Naunyn-Schmiedebergs Arch.Pharmacol. 335: 1–7 (1987). (10.1007/BF00165027) / Naunyn-Schmiedebergs Arch.Pharmacol. by F Dreyer (1987)
  18. J. A. Kauffman, J. F. Way, L. S. Siegel, and L. C. Sellin, Comparison of the action of types A and F botulinum toxin at the rat neuromuscular junction, Toxicol.Appl.Pharmaocol. 79: 211–217 (1985). (10.1016/0041-008X(85)90342-4) / Toxicol.Appl.Pharmaocol. by JA Kauffman (1985)
  19. A. C. Ashton and J. O. Dolly, Microtubule-dissociating drugs and A23187 reveal differences in the inhibition of synaptosomal transmitter release by botulinum neurotoxins type A and B., J.Neurochem. 56: 827–835 (1991). (10.1111/j.1471-4159.1991.tb01998.x) / J.Neurochem. by AC Ashton (1991)
  20. J. D. Black and J. O. Dolly, Interaction of 125-I labelled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves, J.Cell Biol. 103: 521–534 (1986). (10.1083/jcb.103.2.521) / J.Cell Biol. by JD Black (1986)
  21. R. S. Williams, C. K. Tse, J. O. Dolly, P. Hambleton, and J. Melling, Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes, Eur.J.Biochem. 131: 437–445 (1983). (10.1111/j.1432-1033.1983.tb07282.x) / Eur.J.Biochem. by RS Williams (1983)
  22. D. M. Evans, R. S. Williams, C. C. Shone, P. Hambleton, J. Melling, and J. O. Dolly, Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat brain synaptosomal membranes, Eur.J.Biochem. 154: 409–416 (1986). (10.1111/j.1432-1033.1986.tb09413.x) / Eur.J.Biochem. by DM Evans (1986)
  23. J. S. Elston, Botulinum toxin A in clinical medicine, J.Physiol.(Paris). 84: 285–289 (1990). / J.Physiol.(Paris). by JS Elston (1990)
  24. J. O. Dolly, A. de Paiva, B. Poulain, P. Foran, A. Ashton, and L. Tauc: “Bacterial Protein Toxins, Zbl. BaKt. Suppl. 23,” Witholt et al. ed., Gustav Fischer, Stuttgart, Jena, New York (1992).
  25. G. Schiavo, E. Papini, G. Genna, and C. Montecucco, An intact inter-chain disulphide bond is required for the neurotoxicity of tetanus toxin, Infect.Immun. 58: 41364141 (1990). (10.1128/IAI.58.12.4136-4141.1990) / Infect.Immun. by G. Schiavo (1990)
  26. B. Poulain, J. D. F. Wadsworth, C. C. Shone, S. Mochida, S. Lande, J. Melling, J. O. Dolly, and L. Tauc, Mutiple domains of Botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia Neurons, J. Biol. Chem. 264: 21928–21933 (1989). (10.1016/S0021-9258(20)88274-X) / J. Biol. Chem. by B Poulain (1989)
  27. E. A. Maisey, J. D. F. Wadsworth, B. Poulain, C. C. Shone, J. Melling, P. Gibbs, L. Tauc, and J. O. Dolly, Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release, Eur.J.Biochem. 177: 683–691 (1988). (10.1111/j.1432-1033.1988.tb14423.x) / Eur.J.Biochem. by EA Maisey (1988)
  28. A. C. Ashton and J. O. Dolly, Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes, J.Neurochem. 50: 1808–1816 (1988). (10.1111/j.1471-4159.1988.tb02482.x) / J.Neurochem. by AC Ashton (1988)
  29. J. D. Black and J. O. Dolly, Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems, Neuroscience. 23: 767–779 (1987). (10.1016/0306-4522(87)90094-7) / Neuroscience by JD Black (1987)
  30. B. Poulain, A. de Paiva, J. O. Dolly, U. Weller, and L. Tauc, Differences in the temperature dependencies of uptake of botulinum and tetanus toxins in Aplysia neurons,, Neuroscience Lett. 139: 289–292 (1992). (10.1016/0304-3940(92)90573-P) / Neuroscience Lett by B Poulain (1992)
  31. M. S. Santos, P. P. Goncalves, and A. P. Carvalho, Release of gamma[3H]aminobutyric acid from synaptosomes: effect of external cations and of ouabain, Brain Res. 547: 135–141 (1991). (10.1016/0006-8993(91)90584-I) / Brain Res by MS Santos (1991)
  32. J. Molgó, M. Lemeignan, and S. Thesleff, Aminoglycosides and 3,4diaminopyridine on neuromuscular block caused by botulinum type A toxin, Muscle and Nerve. 10: 464–470 (1987). (10.1002/mus.880100514) / Muscle and Nerve by J Molgó (1987)
  33. J. L. Halpern, W. H. Habig, H. Trenchard, and J. T. Russel, Effect of tetanus toxin on oxytocin and vasopressin release from nerve endings of the neurohypophysis, J.Neurochem. 55: 2072–2078 (1990). (10.1111/j.1471-4159.1990.tb05797.x) / J.Neurochem. by JL Halpern (1990)
  34. D. E. Knight, D. A. Tonge, and P. F. Baker, Inhibition of exocytosis in bovine adrenal medullary cells by botulinum toxin type D, Nature. 317: 719–721 (1985). (10.1038/317719a0) / Nature by DE Knight (1985)
  35. P. Marxen, F. Bartels, G. Ahnert-Hilger, and H. Bigalke, Distinct targets for tetanus toxin and botulinum A neurotoxins within the signal transducing pathway in chromaffin cells, Naunyn-Schmeideberg’s Arch.Pharmacol. 344: 387–395 (1991). (10.1007/BF00172577) / Naunyn-Schmeidebergs Arch.Pharmacol. by P Marxen (1991)
  36. M. Verhage, H. McMahon, W. E. J. M. Ghijsen, F. Boomsma, G. Scholter, V. M. Wiegant, and D. G. Nicholls, Differential release of amino acids, neuropeptides, and catecholamines from isolated nerve terminals, Neuron. 6: 517–524 (1991). (10.1016/0896-6273(91)90054-4) / Neuron by M Verhage (1991)
  37. M. Matteoli, C. Haimann, F. Torri-Tarelli, J. M. Polak, B. Ceccarelli, and P. De Camilli, Differential effect of a-latrotoxin on exocytosis from small synaptic vesicles and from large dense-core vesicles containing calcitonin gene-related peptide at the frog neuromuscular junction, Proc.Natl.Acad.Sci.USA. 85: 7366–7370 (1988). (10.1073/pnas.85.19.7366) / Proc.Natl.Acad.Sci.USA. by M Matteoli (1988)
  38. A. K. Thureson-Klein, R. L. Klein, P.-C. Zhu, and J.-Y. Kong, Differential release of transmitters and neuropeptides co-stored in central and peripheral neurons, in: “Cellular and Molecular Basis of Synaptic Transmission,” H. Zimmermann ed., Springer-Verlag, Berlin, Heidelberg (1988). / “Cellular and Molecular Basis of Synaptic Transmission,” H by AK Thureson-Klein (1988)
  39. D. V. Pow and D. W. Golding, “Neurosecretion” by aminergic synaptic terminals in vivo - a study of secretory granule exocytosis in the corpus cardiacum of the flying locust, Neuroscience. 22: 1145–1149 (1987). (10.1016/0306-4522(87)92989-7) / Neuroscience by DV Pow (1987)
  40. J. Cuadras, Non-synaptic release from dense-cored vesicles occurs at all terminal types in crayfish neuropile, Brain Res. 477: 332–335 (1989). (10.1016/0006-8993(89)91423-6) / Brain Res by J Cuadras (1989)
  41. R. Robitaille, E. M. Adler, and M. P. Charlton, Strategic location of calcium channels at transmitter release sites of frog neuromuscular synapses, Neuron. 5: 773–779 (1990). (10.1016/0896-6273(90)90336-E) / Neuron by R Robitaille (1990)
  42. H. T. McMahon and D. G. Nicholls, The bioenergetics of neurotransmitter release, Biochim.Biophys.Acta. 1059: 243–364 (1991). (10.1016/S0005-2728(05)80210-5) / Biochim.Biophys.Acta. by HT Mcmahon (1991)
  43. P. K. Janicki and E. Habermann, Tetanus and botulinum toxins inhibit, and black widow spider venom stimulates the release of methionine-enkephalin-like material in vitro, J.Neurochem. 41: 395–402 (1983). (10.1111/j.1471-4159.1983.tb04755.x) / J.Neurochem. by PK Janicki (1983)
  44. H. T. McMahon, P. Foran, J. O. Dolly, M. Verhage, V. M. Wiegant, and D. G. Nicholls, Tetanus and botulinum toxins type A and B inhibit glutamate, GABA, aspartate and met-enkephalin release from synaptosomes: clues to the locus of action, J.Biol.Chem. In Press (1992). / Press by HT Mcmahon (1992)
  45. F. Vyskocil, E. Nikolsky, and C. Edwards, An analysis of the mechanisms underlying the non-quantal release of acetylcholine at the neuromuscular junction, Neuroscience. 9: 429–435 (1983). (10.1016/0306-4522(83)90305-6) / Neuroscience by F Vyskocil (1983)
  46. C. B. Gundersen and D. J. Jenden, Spontaneous output of acetylcholine from rat diaphragm preparations declines after treatment with botulinum toxin, J.Pharmacol.Exp.Ther. 224: 265–268 (1983). / J.Pharmacol.Exp.Ther. by CB Gundersen (1983)
  47. F. Vyskocil, Inhibition of non-quantal leakage by 2(4phenylpiperidine)cyclohexanol in the mouse diaphragm, Neuroscience Lett. 59: 277–280 (1985). (10.1016/0304-3940(85)90144-2) / Neuroscience Lett by F Vyskocil (1985)
  48. S. D. Merriney, S. H. Young, and A. D. Grinell, Constraints on the interpretation of nonquantal acetylcholine release from frog neuromuscular junctions, Proc.Natl.Acad.Sci. USA. 86: 2098–2102 (1989). (10.1073/pnas.86.6.2098) / Proc.Natl.Acad.Sci. USA. by SD Merriney (1989)
  49. B. Ceccarelli, R. Fesce, F. Grohavaz, and C. Haimann, The effect of potassium on exocytosis of transmitter at the frog neuromuscular junction, J.Physiol.(Lond.). 401: 163183 (1988). (10.1113/jphysiol.1988.sp017156) / J.Physiol.(Lond.). by B. Ceccarelli (1988)
  50. E. S. Vizi, K. Gyires, G. T. Somogyi, and G. Ungvary, Evidence that transmitter can be released from regions of the nerve cell other than presynaptic axon terminal: axonal release of acetylcholine without modulation, Neuroscience. 10: 967–972 (1983). (10.1016/0306-4522(83)90234-8) / Neuroscience by ES Vizi (1983)
  51. M. L. Vitale, A. Rodriguez del Castillo, L. Tchakarov, and J.-M. Trifaro, Cortical filamentous actin disassembly and scinderin redistribution during chromaffin cell stimulation precede exocytosis, a phenomenon not exhibited by gelsolin, J.Cell Biol. 113: 1057–1067 (1991). (10.1083/jcb.113.5.1057) / J.Cell Biol. by ML Vitale (1991)
  52. R. H. Chow, L. von Rüden, and E. Neher, Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells, Nature. 356: 60–63 (1992). (10.1038/356060a0) / Nature by RH Chow (1992)
  53. S. Terakawa, J.-H. Fan, K. Kumakuru, and M. Ohara-Imaizumi, Quantitative analysis of exocytosis directly visualized in living chromaffin cells, Neuroscience Lett. 123: 82–86 (1991). (10.1016/0304-3940(91)90163-N) / Neuroscience Lett by S Terakawa (1991)
  54. P. Marxen and H. Bigalke, Tetanus toxin and botulinum A toxins inhibit stimulated F-actin rearrangements in chromaffin cells, Neuroreport. 2: 33–36 (1991). (10.1097/00001756-199101000-00008) / Neuroreport by P Marxen (1991)
  55. H. von Grafenstein, R. Borges, and D. E. Knight, The effect of botulinum toxin type D on the triggered and constitutive exocytosis/endocytosis cycles in cultures of bovine adrenal medullary cells, FEBS Lett. 298: 118–122 (1992). (10.1016/0014-5793(92)80035-F) / FEBS Lett by H Grafenstein (1992)
  56. E. G. Gray, Presynaptic microtubules and their association with synaptic vesicles, Proc.Roy.Soc.Lond.(Biol.]. 190: 369–372 (1975). (10.1098/rspb.1975.0100) / Proc.Roy.Soc.Lond.(Biol.]. by EG Gray (1975)
  57. N. Hirokawa, K. Sobue, K. Kanda, A. Maruda, and H. Yorifugi, The cytoskeletal architecture of the presynaptic terminal and molecular structure of synapsin I, J.Cell Biol. 108: 111–126 (1989). (10.1083/jcb.108.1.111) / J.Cell Biol. by N Hirokawa (1989)
  58. P. R. Gordon-Weeks, R. D. Burgoyne, and E. G. Gray, Presynaptic microtubules: organization and assembly/ disassembly, Neurosciece. 7: 739–749 (1982). (10.1016/0306-4522(82)90079-3) / Neurosciece by PR Gordon-Weeks (1982)
  59. R. D. Burgoyne and R. Cumming, Taxol stabilizes synaptosomal microtubules without inhibiting acetylcholine release, Brain Res. 280: 190–193 (1983). (10.1016/0006-8993(83)91192-7) / Brain Res by RD Burgoyne (1983)
  60. L. L. Simpson, The origin, structure, and pharmacological activity of botulinum toxin, Pharmacol.Rev. 33: 155–188 (1981). / Pharmacol.Rev. by LL Simpson (1981)
  61. J. D. Black and J. O. Dolly, Interaction of 125 I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis, J.Cell Biol. 103: 535–544 (1986). (10.1083/jcb.103.2.535) / J.Cell Biol. by JD Black (1986)
  62. R. G. Parton, C. D. Ockleford, and D. R. Critchley, Tetanus toxin binding to mouse spinal cord cells: an evaluation of the role of gangliosides in toxin internalization, Brain Res. 475: 118–127 (1988). (10.1016/0006-8993(88)90204-1) / Brain Res by RG Parton (1988)
  63. R. G. Parton, C. D. Ockleford, and D. R. Critchley, A study of the mechanism of internalization of tetanus toxin by primary mouse spinal cord cultures, J.Neurochem. 49: 1057–1068 (1987). (10.1111/j.1471-4159.1987.tb09994.x) / J.Neurochem. by RG Parton (1987)
  64. K. A. Manning, J. T. Erichsen, and C. Evinger, Retrograde transneuronal transport properties of fragment C of tetanus toxin, Neuroscience. 34: 251–263 (1990). (10.1016/0306-4522(90)90319-Y) / Neuroscience by KA Manning (1990)
  65. G. R. Tibbs, A. P. Barrie, F. J. E. Van Mieghem, H. T. McMahon, and D. G. Nicholls, Repetitive action potentials in isolated nerve terminals in the presence of 4aminopyridine: effects on cytosolic free Cat+ and glutamate release, J.Neurochem. 53: 1693–1699 (1989). (10.1111/j.1471-4159.1989.tb09232.x) / J.Neurochem. by GR Tibbs (1989)
  66. A. Banerjee and R. F. Luduena, Kinetics of association and dissociation of colchicine-tubulin complex from brain and renal tubulin. Evidence for the existence of multiple isotypes of tubulin in brain with differential affinity to colchicine, FEBS Lett. 219: 103–107 (1987). (10.1016/0014-5793(87)81199-7) / FEBS Lett by A. Banerjee (1987)
  67. A. Banerjee and R. F. Luduena, Distinct colchicine binding kinetics of bovine brain tubulin lacking the type III isotype of beta-tubulin, J.Biol.Chem. 266: 1689–1691 (1991). (10.1016/S0021-9258(18)52349-8) / J.Biol.Chem. by A Banerjee (1991)
  68. P. W. Baas and M. M. Black, Individual microtubules in the axon consist of domains that differ in both composition and stability, J.Cell Biol. 111: 495–509 (1991). (10.1083/jcb.111.2.495) / J.Cell Biol. by PW Baas (1991)
  69. P. W. Baas, T. Slaughter, A. Brown, and M. M. Black, Microtubule dynamics in axons and dendrites, J.Neurosci.Res. 30: 134–153 (1991). (10.1002/jnr.490300115) / J.Neurosci.Res. by PW Baas (1991)
  70. R. H. Miller, R. J. Lasek, and M. J. Katz, Preferred microtubules for vesicle transport in lobster axons, Science. 235: 220–222 (1987). (10.1126/science.2432661) / Science by RH Miller (1987)
  71. H. Koike, M. Matsumoto, and Y. Umitso, Selective axonal transport in a single cholinergic axon of Aplysia-role for colchicine-resistant microtubules, Neuroscience. 32: 539–555 (1989). (10.1016/0306-4522(89)90100-0) / Neuroscience by H Koike (1989)
  72. F. F. Severin, N. A. Shanina, S. A. Kuznetsov, and V. I. Gelfand, MAP2mediated binding of chromaffin granules to microtubules, FEBS Lett. 282: 65–68 (1991). (10.1016/0014-5793(91)80445-9) / FEBS Lett by FF Severin (1991)
  73. Z. Luo, B. Shafit-Zagardo, and J. Erlichman, Identification of the MAP2- and P75-binding domain in the regulatory subunit (RII beta) of type II cAMP-dependent protein kinase, J.Biol.Chem. 265: 21804–21810 (1990). (10.1016/S0021-9258(18)45811-5) / J.Biol.Chem. by Z Luo (1990)
  74. R. Donato, I. Giambanco, and M. C. Aisa, Molecular interaction of S-100 proteins with microtubule proteins in vitro, J.Neurochem. 53: 566–571 (1989). (10.1111/j.1471-4159.1989.tb07371.x) / J.Neurochem. by R Donato (1989)
  75. Shimada, H. Ishikawa, and K. Wakabayashi, Role of microtubules in hormone secretion function of the rat anterior pituitary, Protoplasma. Supp1. 2: 145–157 (1988). (10.1007/978-3-7091-9011-1_16)
  76. K. Parczyk, W. Haase, and C. Kondor-Koch, Microtubules are involved in the secretion of proteins at the apical cell surface of the polarized epithelial cell Madrin-Darby canine kidney, J.Biol.Chem. 264: 16837–16846 (1989). (10.1016/S0021-9258(19)84782-8) / J.Biol.Chem. by K Parczyk (1989)
  77. G. Herman, G. Busson, M. J. Gorbunoff, P. Mauduit, S. N. Timasheff, and B. Rossignol, Colchicine analogues that bind reversibility to tubulin define microtubular requirements for newly synthesized protein secretion in rat lacrimal gland, Proc.Natl.Acad. Sci. USA. 86: 4515–4519 (1989). (10.1073/pnas.86.12.4515) / Proc.Natl.Acad. Sci. USA. by G Herman (1989)
Dates
Type When
Created 12 years ago (Aug. 10, 2013, 5:51 a.m.)
Deposited 4 months ago (April 30, 2025, 9:48 a.m.)
Indexed 4 months ago (May 1, 2025, 12:10 p.m.)
Issued 32 years, 8 months ago (Jan. 1, 1993)
Published 32 years, 8 months ago (Jan. 1, 1993)
Published Print 32 years, 8 months ago (Jan. 1, 1993)
Funders 0

None

@inbook{Ashton_1993, title={Factors Underlying the Characteristic Inhibition of the Neuronal Release of Transmitters by Tetanus and Various Botulinum Toxins}, ISBN={9781475795424}, url={http://dx.doi.org/10.1007/978-1-4757-9542-4_20}, DOI={10.1007/978-1-4757-9542-4_20}, booktitle={Botulinum and Tetanus Neurotoxins}, publisher={Springer US}, author={Ashton, Anthony C. and de Paiva, Anton M. and Poulain, Bernard and Tauc, Ladislav and Dolly, J. Oliver}, year={1993}, pages={191–213} }